These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

484 related items for PubMed ID: 6883380

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Carcinoembryonic antigen, ferritin, and tissue polypeptide antigen in serum and tissue. Relationship with the receptor content in breast carcinoma.
    Gion M, Mione R, Dittadi R, Fasan S, Pallini A, Bruscagnin G.
    Cancer; 1986 Mar 01; 57(5):917-22. PubMed ID: 3943025
    [Abstract] [Full Text] [Related]

  • 24. [The tumor markers CEA, TPA and CA 19-9 and ferritin and osteocalcin in follow-up studies in breast cancer].
    Schatz C, von Lieven H, Mulders M, Rowold J, Stracke H, Müller H, Grebe SF, Schatz H.
    Wien Klin Wochenschr; 1985 Dec 06; 97(23):873-9. PubMed ID: 3878042
    [Abstract] [Full Text] [Related]

  • 25. [Changes in carcinoembryonic antigen and tissue polypeptide antigen in monitoring the post-operative course of some tumor types].
    Ciaccio B, Caponi A, Cappetti P, Fanciullacci A, Bartoli P, Berti P.
    Quad Sclavo Diagn; 1985 Jun 06; 21(2):199-205. PubMed ID: 4080962
    [Abstract] [Full Text] [Related]

  • 26. [Advantages and limitations of combined assays of 4 serum markers in various types of malignant neoplasms].
    Lanza E, Coda C, Ramella S, Ciambellotti E, Moro G, Cartia GL.
    Minerva Med; 1986 Sep 15; 77(34-35):1521-5. PubMed ID: 3463886
    [Abstract] [Full Text] [Related]

  • 27. [CEA, GICA, TPA, fibrinopeptide-A, gamma-GT and gastric cancer. A contribution to the rationalization of a combined assay].
    Abbasciano V, Graziano L, Arcudi D, Tassinari D, Nielsen I, Sartori S.
    Recenti Prog Med; 1991 Oct 15; 82(10):517-9. PubMed ID: 1684676
    [Abstract] [Full Text] [Related]

  • 28. The role of tumour markers (CEA, TPA, CA 19-9) in colon and rectum carcinomas.
    Cangemi V, Volpino P, Fiori E, Giammarco A, Piat G.
    J Nucl Med Allied Sci; 1987 Oct 15; 31(2):189-93. PubMed ID: 3476692
    [No Abstract] [Full Text] [Related]

  • 29. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
    Juang CM, Wang PH, Yen MS, Lai CR, Ng HT, Yuan CC.
    Gynecol Oncol; 2000 Jan 15; 76(1):103-6. PubMed ID: 10620449
    [Abstract] [Full Text] [Related]

  • 30. Occurrence of carcinoembryonic antigen in tumor tissue and serum of breast cancer patients.
    Stratil P, Rejthar A, Lang BA, Kocent A, Pacovský Z, Matoska J.
    Neoplasma; 1988 Jan 15; 35(1):69-76. PubMed ID: 3352839
    [Abstract] [Full Text] [Related]

  • 31. [Clinical evaluation of a combination assay of CEA, CA-19-9 and TPA in patients with colorectal cancer].
    Nishida O, Shiroto H, Satoh N, Nakajima Y, Manabe K, Kondoh Y, Sano F, Uchino J.
    Gan No Rinsho; 1988 Aug 15; 34(9):1096-100. PubMed ID: 3172515
    [Abstract] [Full Text] [Related]

  • 32. [CEA and TPA in serum and pleural exudates in patients with pulmonary neoplasms: preliminary results].
    Iannucci F, di Matteo L, Di Martino G, Tranchese D, Auriemma L, Micillo E, Catena E.
    Arch Monaldi; 1983 Aug 15; 38(1-2):3-8. PubMed ID: 6675556
    [No Abstract] [Full Text] [Related]

  • 33. [A study of localizations and serum data; four tumor markers (CA125, CA19-9, CEA and TPA) in ovarian cancers].
    Kataoka A, Yakushiji M.
    Nihon Gan Chiryo Gakkai Shi; 1990 Jan 20; 25(1):47-54. PubMed ID: 2157782
    [Abstract] [Full Text] [Related]

  • 34. [Clinical usefulness of serum TPA, IAP and CEA levels in gynecological cancer].
    Saitoh S, Nakanishi A, Noda T, Ando Y, Kamamoto Y, Moriyama I, Ichijo M.
    Nihon Gan Chiryo Gakkai Shi; 1984 Aug 20; 19(7):1496-504. PubMed ID: 6520506
    [No Abstract] [Full Text] [Related]

  • 35. [Auxiliary value of TPA in diagnosing neoplastic diseases].
    Mizushima Y, Nakamura F, Yokoyama A, Morikage T, Kawasaki S, Hoshino K, Maruyama M, Yamashita N, Yano S.
    Gan No Rinsho; 1986 Jun 20; 32(7):779-82. PubMed ID: 3735675
    [Abstract] [Full Text] [Related]

  • 36. The clinical significance of tissue polypeptide antigen in breast cancer patients.
    Mross K, Bandlow G.
    Anticancer Res; 1986 Jun 20; 6(2):223-5. PubMed ID: 3707059
    [Abstract] [Full Text] [Related]

  • 37. Combination of tissue polypeptide antigen (TPA) and carcino embryonic antigen (CEA) in different types of cancer.
    Falcone F, Sabbatani S, Fini A, Turba E, Magri P, D'Ales A.
    Nucl Med Commun; 1985 May 20; 6(5):299-304. PubMed ID: 4034127
    [Abstract] [Full Text] [Related]

  • 38. Chemiluminometric determination of tissue polypeptide antigen (TPA), cancer antigen 15-3 (CA 15-3), carcinoembryonic antigen (CEA) in comparison with vascular endothelial growth factor (VEGF) in follow-up of breast cancer.
    Findeisen R, Albrecht S, Richter B, Deutschmann K, Zimmermann T, Distler W.
    Luminescence; 2000 May 20; 15(5):283-9. PubMed ID: 11038485
    [Abstract] [Full Text] [Related]

  • 39. [Serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
    Matsushima M, Kuwabara T, Miyamae K, Hachiya A, Kawahara M, Fukasawa K, Yagishita T, Tajima M, Sawamura Y, Shirai M.
    Hinyokika Kiyo; 1984 Jul 20; 30(7):869-75. PubMed ID: 6507205
    [Abstract] [Full Text] [Related]

  • 40. Clinical significance of different serum tumor markers in gynecological malignancies.
    Paulick R, Caffier H, Horner G, Lang K, Filbry E.
    Cancer Detect Prev; 1985 Jul 20; 8(1-2):115-20. PubMed ID: 4064031
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.